Overview of Personalized Medicine in GI Cancers

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Cancer biomarkers may be used for prevention (identification of patients at high risk for cancer), estimating prognosis and/or repsonse to conventional chemotherapies, or guide the use of specific targeted therapies. This overview provides examples in each category for gastrointestinal cancers and reviews current concepts in personalized medicine.

Original languageEnglish (US)
Pages (from-to)1641-1644
Number of pages4
JournalJournal of Gastrointestinal Surgery
Volume16
Issue number9
DOIs
StatePublished - Sep 2012

Fingerprint

Precision Medicine
Gastrointestinal Neoplasms
Tumor Biomarkers
Drug Therapy
Neoplasms
Therapeutics

Keywords

  • Personalized medicine
  • Targeted therapy

ASJC Scopus subject areas

  • Surgery
  • Gastroenterology

Cite this

Overview of Personalized Medicine in GI Cancers. / Chao, Celia.

In: Journal of Gastrointestinal Surgery, Vol. 16, No. 9, 09.2012, p. 1641-1644.

Research output: Contribution to journalArticle

@article{0b6363661b3d4073a5c8a283355fb93f,
title = "Overview of Personalized Medicine in GI Cancers",
abstract = "Cancer biomarkers may be used for prevention (identification of patients at high risk for cancer), estimating prognosis and/or repsonse to conventional chemotherapies, or guide the use of specific targeted therapies. This overview provides examples in each category for gastrointestinal cancers and reviews current concepts in personalized medicine.",
keywords = "Personalized medicine, Targeted therapy",
author = "Celia Chao",
year = "2012",
month = "9",
doi = "10.1007/s11605-012-1949-8",
language = "English (US)",
volume = "16",
pages = "1641--1644",
journal = "Journal of Gastrointestinal Surgery",
issn = "1091-255X",
publisher = "Springer New York",
number = "9",

}

TY - JOUR

T1 - Overview of Personalized Medicine in GI Cancers

AU - Chao, Celia

PY - 2012/9

Y1 - 2012/9

N2 - Cancer biomarkers may be used for prevention (identification of patients at high risk for cancer), estimating prognosis and/or repsonse to conventional chemotherapies, or guide the use of specific targeted therapies. This overview provides examples in each category for gastrointestinal cancers and reviews current concepts in personalized medicine.

AB - Cancer biomarkers may be used for prevention (identification of patients at high risk for cancer), estimating prognosis and/or repsonse to conventional chemotherapies, or guide the use of specific targeted therapies. This overview provides examples in each category for gastrointestinal cancers and reviews current concepts in personalized medicine.

KW - Personalized medicine

KW - Targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=84865486596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865486596&partnerID=8YFLogxK

U2 - 10.1007/s11605-012-1949-8

DO - 10.1007/s11605-012-1949-8

M3 - Article

C2 - 22744640

AN - SCOPUS:84865486596

VL - 16

SP - 1641

EP - 1644

JO - Journal of Gastrointestinal Surgery

JF - Journal of Gastrointestinal Surgery

SN - 1091-255X

IS - 9

ER -